Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

[A case report of combined small cell lung cancer with EGFR mutation and treatment experience].

Guo Y, Qu L, Shao M, Wang X, Sun H, Ma K.

Zhongguo Fei Ai Za Zhi. 2014 Jun 20;17(6):511-4. doi: 10.3779/j.issn.1009-3419.2014.06.14. Chinese. No abstract available.

2.

Epidermal Growth Factor Receptor Mutation in Small Cell Lung Cancer Patients in an Indian Tertiary Care Oncology Hospital: Incidence and Clinical Outcome.

Noronha V, Chougule A, Joshi A, Kumar R, Patil VM, Prabhash K.

Clin Oncol (R Coll Radiol). 2016 May;28(5):342-3. doi: 10.1016/j.clon.2015.11.013. No abstract available.

PMID:
26683257
3.

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.

van Riel S, Thunnissen E, Heideman D, Smit EF, Biesma B.

Ann Oncol. 2012 Dec;23(12):3188-9. doi: 10.1093/annonc/mds525. No abstract available.

PMID:
23079729
4.

Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.

Takagi Y, Nakahara Y, Hosomi Y, Hishima T.

BMC Cancer. 2013 Nov 7;13:529. doi: 10.1186/1471-2407-13-529.

5.

Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer.

Sun HB, Ou W, Li Y, Fang Q, Qin J, Zhang L, Wang SY.

Clin Lung Cancer. 2013 Jul;14(4):376-82. doi: 10.1016/j.cllc.2012.10.008.

PMID:
23291256
6.

Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment.

Ham JS, Kim S, Kim HK, Byeon S, Sun JM, Lee SH, Ahn JS, Park K, Choi YL, Han J, Park W, Ahn MJ.

J Thorac Oncol. 2016 Jan;11(1):e1-4. doi: 10.1016/j.jtho.2015.09.013. No abstract available.

7.

Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung.

Ma AT, Chan WK, Ma ES, Cheng T, Cheng PN.

Acta Oncol. 2012 Apr;51(4):557-9. doi: 10.3109/0284186X.2011.636757. No abstract available.

PMID:
22129360
8.

Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.

Kotsakis A, Georgoulias V.

Expert Opin Pharmacother. 2010 Oct;11(14):2363-89. doi: 10.1517/14656566.2010.498581. Review.

PMID:
20586711
9.

Is FISH floating or still swimming in the lung cancer ocean?

Cappuzzo F, Camidge DR, Varella-Garcia M.

Ann Oncol. 2011 Mar;22(3):493-9. doi: 10.1093/annonc/mdq752. No abstract available. Erratum in: Ann Oncol. 2011 Jun;22(6):1467.

PMID:
21292645
10.

Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.

Kondo M, Yokoyama T, Fukui T, Yoshioka H, Yokoi K, Nagasaka T, Imaizumi K, Kume H, Hasegawa Y, Shimokata K, Sekido Y.

Lung Cancer. 2005 Dec;50(3):385-91.

PMID:
16140420
11.

Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

Zhang Y, Li XY, Tang Y, Xu Y, Guo WH, Li YC, Liu XK, Huang CY, Wang YS, Wei YQ.

Lung Cancer. 2013 Aug;81(2):302-5. doi: 10.1016/j.lungcan.2013.04.005.

PMID:
23683536
12.

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.

Huang SF, Liu HP, Li LH, Ku YC, Fu YN, Tsai HY, Chen YT, Lin YF, Chang WC, Kuo HP, Wu YC, Chen YR, Tsai SF.

Clin Cancer Res. 2004 Dec 15;10(24):8195-203.

13.

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.

Lozano MD, Zulueta JJ, Echeveste JI, Gúrpide A, Seijo LM, Martín-Algarra S, Del Barrio A, Pio R, Idoate MA, Labiano T, Perez-Gracia JL.

Oncologist. 2011;16(6):877-85. doi: 10.1634/theoncologist.2010-0155.

14.

[Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer].

Duan JC, An TT, Wu MN, Yang L, Bai H, Wang ZJ, Wang YY, Zhuo ML, Zhao J, Wang SH, Wang J.

Zhonghua Jie He He Hu Xi Za Zhi. 2012 May;35(5):323-8. Chinese.

PMID:
22883988
15.

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Myerson JS, Iqbal SA, O'Brien ME, Popat S.

Clin Lung Cancer. 2010 Sep 1;11(5):E5-8. doi: 10.3816/CLC.2010.n.047.

PMID:
20837451
16.

Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.

Alam N, Gustafson KS, Ladanyi M, Zakowski MF, Kapoor A, Truskinovsky AM, Dudek AZ.

Clin Lung Cancer. 2010 Sep 1;11(5):E1-4. doi: 10.3816/CLC.2010.n.046.

PMID:
20837450
17.

Epidermal growth factor receptor mutations in small cell lung cancer.

Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, Mitsudomi T, Yatabe Y.

Clin Cancer Res. 2008 Oct 1;14(19):6092-6. doi: 10.1158/1078-0432.CCR-08-0332.

18.

Third-generation EGFR-TKIs—a new hope for NSCLC.

Akkermans R.

Lancet Respir Med. 2014 Jul;2(7):520. No abstract available.

PMID:
25140365
19.

High epidermal growth factor receptor amplification rate but low mutation frequency in Middle East lung cancer population.

Al-Kuraya K, Siraj AK, Bavi P, Al-Jommah N, Ezzat A, Sheikh S, Amr S, Al-Dayel F, Simon R, Guido S.

Hum Pathol. 2006 Apr;37(4):453-7.

PMID:
16564920
20.

Chasing mutations in the epidermal growth factor in lung cancer.

Dowell JE, Minna JD.

N Engl J Med. 2005 Feb 24;352(8):830-2. No abstract available.

Items per page

Supplemental Content

Support Center